Lanean...

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN

The possibility of atorvastatin in reducing the risk of periprocedural myocardial infarction and other cardiovascular events in patients with percutaneous coronary intervention is discussed.

Gorde:
Xehetasun bibliografikoak
Egile nagusia: N. G. Gogolashvili
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Saila:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Gaiak:
Sarrera elektronikoa:https://www.rpcardio.com/jour/article/view/192
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!